Biotron
- Short interest
- 0.03%
- +0.01 pp 30d
- as of 20 Nov 2025
- Reported shorts
- 421.6K
- Shares on issue
- 1.526B
Biotron (BIT) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $0M (source: ASX (Markit))vs $0M (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 14 Oct 2026
- NPAT
- −$1.5MM (source: ASX (Markit))vs −$318.6KM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 14 Oct 2026
- EPS (diluted)
- −$0.001T (source: Derived: trailing 12 months at year end)vs $0.000T (source: Derived: trailing 12 months at year end) (FY25)
- Derived: trailing 12 months at year end, as at 14 Oct 2026
- Rev YoY
- n/aFY
- EPS YoY
- n/aTTM
- ASX (Markit)
- Derived: trailing 12 months at year end
Summary of Full Year Statutory Accounts and Appendix 4E, 27 Aug 2026
Biotron reported a net loss of $1,518,303 for the year ended 30 June 2026, a 376.6% increase from the prior year, with no revenue generated. No dividends were declared. The company is focused on advancing its SedRxTM anaesthetic and HBV antiviral programs, with key regulatory feedback received from the EMA post-period.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026
- Gross margin
- n/a
- Operating margin
- n/a
- Net margin
- n/a
- FCF margin
- n/a
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- n/a
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- n/a
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Sources: ASX (Markit) and Derived: trailing 12 months at year end, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $0M (source: ASX (Markit)) | $0M (source: ASX (Markit)) | $0M (source: ASX (Markit)) | $0M (source: ASX (Markit)) |
| Operating income | −$2.1MT (source: Derived: trailing 12 months at year end) | n/a | −$5.2M | −$5.0M |
| EBITDA | −$2.1MT (source: Derived: trailing 12 months at year end) | n/a | −$3.4M | −$3.4M |
| EBIT | −$2.1MT (source: Derived: trailing 12 months at year end) | n/a | −$3.4M | −$3.5M |
| Interest expense | n/a | n/a | $1.1K | $4.4K |
| Pretax income | −$1.5MT (source: Derived: trailing 12 months at year end) | n/a | −$3.4M | −$3.5M |
| Tax | $0T (source: Derived: trailing 12 months at year end) | n/a | $0 | $0 |
| NPAT | −$1.5MM (source: ASX (Markit)) | −$318.6KM (source: ASX (Markit)) | −$3.4M | −$3.5M |
| Net interest income | $37.8KT (source: Derived: trailing 12 months at year end) | n/a | $69.5K | $115.3K |
| EPS basic | −$0.001T (source: Derived: trailing 12 months at year end) | n/a | −$0.003 | −$0.004 |
| EPS diluted | −$0.001T (source: Derived: trailing 12 months at year end) | $0.000T (source: Derived: trailing 12 months at year end) | −$0.003 | −$0.004 |
| Shares | n/a | n/a | 902.3M | 901.9M |
- ASX (Markit)
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- Full Year Statutory Accounts and Appendix 4EAnnual Results27 Aug 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report21 Jul 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report29 Apr 2026via asx_announcements
- Half Yearly Report and AccountsHalf Year Results26 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report29 Jan 2026via asx_announcements
- Annual Report for the year ended 30 June 2023Annual Report31 Dec 2025via crawler
- Financial ReportAnnual Report31 Dec 2025via crawler
- Presentation to investorsFinancial Report31 Dec 2025via crawler
- Biotron Investor WebinarFinancial Report31 Dec 2025via crawler
- Annual Report for the year ended 30 June 2024Annual Report31 Dec 2025via crawler
Showing 10 of 25 reports